Nah, a partner will want an equity stake rather than a (non-voting) preferred equity stake. The RPS is most probably used to fund upfront development costs of other reformulated chemo drugs, then the cash flows from fondaparinus used to pay preferred dividends. The chairman is an ex-ibanker, he clearly knows how to maximise a DCF
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable